Tag Archives: Drugs

Gold Sensor Lives Under Skin for Months Measuring Drugs and Biomarkers

Researchers at the Johannes Gutenberg University Mainz in Germany have developed an implantable biosensor that can measure concentrations of various biomarkers and drugs in the body. Unlike many implantable devices, the sensor can reside in place under the skin for many months without being rejected by the body or losing its functionality. The system uses… Read More »

How bacteria defeat drugs that fight cystic fibrosis

University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic fibrosis. The research was published Feb. 23 in the journal Cell Reports. Cystic fibrosis is a life-threatening disease that causes persistent lung infections and limits a… Read More »

The Social Determinants of Prescription Drugs – A View From CoverMyMeds

The COVID-19 pandemic forced consumers to define what were basic or essential needs to them; for most people, those items have been hygiene products, food, and connectivity to the Internet. There’s another good that’s essential to people who are patients: prescription drugs. A new report from CoverMyMeds details the current state of medication access weaving… Read More »

It’s possible to end HIV epidemics among people who inject drugs in low- and middle-income countries

HIV incidence is below 0.1% per year among people who inject drugs in a large Vietnamese city, Professor Don Des Jarlais and colleagues report in the December issue of AIDS. They say the data clearly demonstrate that it is possible to achieve very low HIV incidence – ‘to end an HIV epidemic’ – among people… Read More »

COVID antibody drugs from Lilly and Regeneron won’t do much to boost their top lines: analysts

When Eli Lilly won emergency use authorization for its COVID-19 antibody drug, bamlanivimab, earlier this week, beating Regeneron to the finish line in a closely watched race, it was viewed as both good news and bad news. Now that Wall Street analysts have had a couple of days to digest the approval, some have concluded… Read More »